BPC157 (Bepecin, PL 14736), a small, chemically synthesised pentadecapeptide and a partial sequence of the human gastric juice protein BPC, which has been shown to be safe in clinical trials for inflammatory bowel disease and may be able to cure intestinal anastomosis dehiscence.
headaches or dizziness
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials
Functioning as a potent exercise mimetic, this small-molecule compound enhances mitochondrial function, fatty acid oxidation, and oxidative muscle fiber composition, thereby improving exercise endurance, cardiac metabolic efficiency, and systemic energy expenditure without increasing food intake 1-4
Compound: Body Protection Compound-157 (BPC-157) Concentration: 5mg per vial Format: Lyophilized Powder Chemical Classification: Pentadecapeptide / Gastric Signaling Peptide Chemical Profile: BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids
